ABBV vs INCY
By Alex · Tickerpine
AbbVie Inc. vs Incyte Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | INCY |
|---|---|---|
| Price | $248.76 | $120.77 |
| Market cap | $439.59B | $24.48B |
| P/E ratio | 70.5 | 15.4 |
| ROE | — | 30.67% |
| Profit margin | 9.80% | 27.71% |
| Revenue growth | 10.20% | 37.70% |
| Dividend yield | 2.77% | — |
| Beta | 0.28 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs INCY in plain English
- ABBV is the bigger company — about 18.0× the market cap of INCY.
- INCY is cheaper on earnings (P/E 15.4 vs 70.5).
- INCY is growing revenue faster (38% vs 10%).
- ABBV pays a dividend (2.77%) while the other effectively doesn't.
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
INCY return calculator
See what $1,000 in Incyte Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.